tradingkey.logo
tradingkey.logo
Search

Progyny Inc

PGNY
Add to Watchlist
31.130USD
-0.360-1.14%
Close 07-31 16:00ETQuotes delayed by 15 min
2.44BMarket Cap
38.60P/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.14%

5 Days

-0.19%

1 Month

+5.70%

6 Months

+30.41%

Year to Date

+21.22%

1 Year

+38.42%

Key Figures
31.400Open
31.840High
974.61KVolume
38.60P/E TTM
21.21P/E Dynamic
--Dividend TTM
1.17%Turnover Ratio
31.490Prev. Close
31.015Low
23.32MTurnover
47.76P/E Static
5.03P/B
0.00%Div Yield TTM
9.48%ROA
28.75052wk High
0.89Volume Ratio
54.34MNet Profit
83.37MShares
0.8065EPS TTM
1.02Beta
14.93%ROE
16.10052wk Low
2.62%Amplitude
25.29%Gross Margin
2.44BMarket Cap
0.70Reward/Risk
2.60%Risk Rate

TradingKey Stock Score of Progyny Inc

Currency: USD Updated: 2026-07-31

Key Insights

Progyny Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 32.90.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Progyny Inc's Score

Industry at a Glance

Industry Ranking
17 / 75
Overall Ranking
91 / 4281
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Progyny Inc Highlights

StrengthsRisks
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 18.38% year-on-year.
Fairly Valued
The company’s latest PE is 38.60, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 88.51M shares, decreasing 26.54% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 140.11K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.26.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
32.900
Target Price
+4.88%
Upside Space

Progyny Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 11 analysts
Buy
Current Rating
32.900
Target Price
+5.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

9
Total
23
Median
20
Average
Company name
Ratings
Analysts
Progyny Inc
PGNY
11
Unitedhealth Group Inc
UNH
30
Humana Inc
HUM
29
Elevance Health Inc
ELV
25
Cigna Group
CI
25
Centene Corp
CNC
22
1
2

Indicators

Indicators
Sell(3)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.578
Neutral
RSI(14)
57.063
Neutral
STOCH(KDJ)(9,3,3)
45.830
Neutral
ATR(14)
1.025
Low Volatility
CCI(14)
-38.390
Neutral
Williams %R
61.722
Sell
TRIX(12,20)
0.458
Sell
StochRSI(14)
16.118
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
31.268
Sell
MA10
31.359
Sell
MA20
31.412
Sell
MA50
28.435
Buy
MA100
23.560
Buy
MA200
23.343
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Progyny Inc Info

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Ticker SymbolPGNY
CompanyProgyny Inc
CEOAnevski (Peter)
Websitehttps://www.progyny.com/

Shareholders

Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.19%
Vanguard Portfolio Management, LLC
6.84%
Kleiner, Perkins, Caufield & Byers
6.48%
Fidelity Management & Research Company LLC
5.67%
State Street Investment Management (US)
3.77%
Other
63.06%

FAQs

What is the current price of Progyny Inc (PGNY)?

The current price of Progyny Inc (PGNY) is 31.13.

What is the symbol of Progyny Inc?

The ticker symbol of Progyny Inc is PGNY.

What is the 52-week high of Progyny Inc?

The 52-week high of Progyny Inc is 28.75.

What is the 52-week low of Progyny Inc?

The 52-week low of Progyny Inc is 16.10.

What is the market capitalization of Progyny Inc?

The market capitalization of Progyny Inc is 2.60B.

Is Progyny Inc (PGNY) currently rated as Buy, Hold, or Sell?

According to analysts, Progyny Inc (PGNY) has an overall rating of Buy, with a price target of 32.90.

What is the Earnings Per Share (EPS TTM) of Progyny Inc (PGNY)?

The Earnings Per Share (EPS TTM) of Progyny Inc (PGNY) is 0.68.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.